X-linked Agammaglobulinemia of Bruton

 

Epidemiology and Etiology:

·         Mutations in Btk (B-cell tyrosine kinase)

·         Associated with the antigen receptor complex of pre-B and mature B cells

·         Failure of pro-B and pre-B cells to mature into B cells

·         B cell maturation stops after the rearrangement of the heavy chain genes

·         Light chain genes are not rearranged and therefore not produced

·         Free heavy chains are found in the cytoplasm

·         T cell mediated reactions are entirely normal

·         Males almost exclusively (X-linked)

·         6 months to 2 years presentation

·         Maternal immunoglobulins are depleted at ~6mo

·          

 

Common sites:

·         Recurrent bacterial infections

·         Respiratory tract

·         Sinusitis

·         Pharyngitis

·         Otitis media

·         Bronchitis

·         Pneumonia

·         Viral infections

·         Gastrointestinal tract

·         CNS via the blood

·         Arthritis (35%)

 

Gross features:

·          

 

Histologic features:

·         Germinal centers are underdeveloped or rudimentary

·         Pre-B cells in bone marrow are present in normal numbers

·         CD19+, membrane immunoglobulins -

·         Plasma cells absent

 

Immunophenotype:

Marker:

Sensitivity:

Specificity:

 

 

 

 

Molecular features:

·         Btk gene is on Xq21.22

 

Other features:

·         B cells absent or markedly decreased in peripheral blood

·         Immunoglobulin levels in serum depressed

·         Plasma cells absent

·         Recurrent bacterial infections

·         Haemophilus influenza

·         Streptococcus pneumonia

·         Staphylococcus aureus

·         Viral infections

·         Enteroviruses

·         Echovirus

·         Poliovirus (ex. live immunization)

·         Coxsackievirus

·         Protozoal infections

·         Giardia lamblia

·         Autoimmune diseases occur with increased frequency

·         Arthritis

·         Dermatomyositis

·         Treatment is replacement immunoglobulin therapy

·         Without treatment, most patients succumb to infection in infancy or early childhood

·         With treatment, most reach adulthood

 

References:

·         Kumar V, Fausto N, Abbas A. Robbins & Cotran Pathologic Basis of Disease, Seventh Edition. 7th ed. Saunders; 2004.